Ube-shi, Yamaguchi, Japan

Teruo Nishida


 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Nishinomiya-shi, Hyogo, JP (1995)
  • Yamaguchi JP (2001)
  • Ube-shi, Yamaguchi JP (2006 - 2010)
  • Ube, JP (2012)

Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Teruo Nishida: Innovator in Ophthalmology and Dermatology

Introduction

Teruo Nishida is a prominent inventor based in Ube-shi, Yamaguchi, Japan. He has made significant contributions to the fields of ophthalmology and dermatology, holding a total of 7 patents. His innovative work focuses on developing therapeutic compositions that address critical medical needs.

Latest Patents

Nishida's latest patents include an ophthalmological composition aimed at treating corneal disorders. This invention seeks to identify the minimum activity expression site of fibronectin and clarify its actions in relation to ophthalmological applications. The composition features a peptide, PHSRN (SEQ ID NO: 1), or its derivatives, which serve as effective components in ophthalmic formulations. Additionally, he has developed methods for treating skin wounds, which involve administering a composition containing specific peptides and pharmaceutically acceptable additives to patients in need.

Career Highlights

Throughout his career, Teruo Nishida has worked with notable companies, including Santen Pharmaceutical Co., Ltd. His expertise in the medical field has allowed him to contribute to advancements in therapeutic methods and compositions.

Collaborations

Nishida has collaborated with esteemed colleagues such as Masatsugu Nakamura and Makoto Inui. These partnerships have further enhanced his research and development efforts in the medical domain.

Conclusion

Teruo Nishida's innovative contributions to ophthalmology and dermatology highlight his commitment to improving patient care through effective therapeutic solutions. His work continues to influence the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…